Skip to main content

Displaying 1 - 20 of 1547

Joint Statement of the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice to the Virginia Certificate of Public Need Work Group

Date
Matter Number
V150011
The FTC and DOJ Antitrust Division jointly submitted a statement, in response to a request by Virginia State Delegate Kathy Byron, suggesting that Virginia consider whether its COPN program best...

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
221 0114
Docket Number
9437
Case Status
Pending

SuperGoodDeals.com, Inc.

The FTC filed a complaint against SuperGoodDeals.com, Inc. and its owner, Kevin J. Lipsitz, alleging that the defendants falsely promised consumers next-day shipping of facemasks and other personal protective equipment (PPE) to deal with the coronavirus pandemic. In addition, the FTC alleged that some of the other merchandise sold through the SuperGoodDeals website were falsely advertised as “authentic” or “certified.”

Kevin Lipsitz, who defrauded consumers by falsely promising “next day” shipping of facemasks and respirators to consumers at the height of the COVID-19 pandemic, will be banned from selling personal protective equipment (PPE) and be required to turn over more than $145,000 to the FTC.

In December 2024, the FTC sent more than $114,000 to consumers who were deceived by “next day shipping” claims on badly needed personal protective equipment (PPE) by online seller SuperGoodDeals.com.

Type of Action
Federal
Last Updated
FTC Matter/File Number
202 3135
Case Status
Pending
Plain Language Guidance

Mobile Health App Interactive Tool

Date
Privacy and security are important considerations for any app—and especially apps that collect and share consumers’ health information. As you design, market, and distribute your mobile health app...

LCA-Vision Inc. d/b/a LasikPlus

In January 2023, the FTC issued an order requiring Ohio-based LCA-Vision, doing business as LasikPlus and Joffe MediCenter, to pay $1.25 million for using deceptive bait-and-switch advertising to trick consumers into believing they could have their vision corrected for less than $300. The order also bans the defendants from making the misrepresentations detailed in the complaint. The Commission approved the final consent order in March 2023. In October 2024, the FTC announced it was returning $1.1 million to defrauded consumers.

Type of Action
Federal
Last Updated
FTC Matter/File Number
1923157
Case Status
Pending